Clinical trials
ReSScue
Aiming to reduce disease-related gastro-intestinal symptoms in systemic sclerosis (SSc) by repeat intestinal infusions of Anaerobic Cultivated Human Intestinal Microbiome (ACHIM); a Phase II, randomized, double-blinded placebo-controlled 20 week multicentre study.
Nor-mILDer
Home based clinical management of Interstitial Lung Disease (ILD) in systemic rheumatic conditions; the Nor-mILDeR randomized strategy trial.
RMD-mILDer
Develop Nor-mILDer to an international multi-centre RCT with Oslo, Zurich and Bucharest as sites. Approximately 311 participants will be screened to include 218 candidates with 109 in each study arm